NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
Hampartsoum B. Barsoumian(The University of Texas MD Anderson Cancer Center), James W. Welsh(The University of Texas MD Anderson Cancer Center)
Cited by 17
Related Papers
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases
|JAMA Oncology|2019|226
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
|Radiation Oncology|2009|114
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
|Journal for ImmunoTherapy of Cancer|2020|93
Bone morphogenetic protein 7 promotes resistance to immunotherapy
|Nature Communications|2020|58